Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | CLYMClimb Bio, Inc.FY2025 · Dec |
|---|---|
| Revenue | — |
| Revenue, yoy | — |
| Net income | $59.85M |
| Net income, yoy | +19.0% |
| Net margin | — |
| Free cash flow | $54.54M |
| FCF margin | — |
| EPS, diluted | $0.88 |
Add another company.
No annual figures on file for this.